MedTrace Logo

Effect Of Psychoeducation On Substance Craving Levels And Psychological Resilience

NCT07581353 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-05-12

No results posted yet for this study

Summary

What is known on the subject? Substance use disorder is a chronic condition with high relapse risk, and individuals under probation supervision are particularly vulnerable. Psychoeducation and psychological resilience are important factors in reducing craving and improving treatment outcomes.

What the paper adds to existing knowledge

What are the implications for practice? Psychoeducation can be effectively used by psychiatric nurses in probation settings to support recovery. Strengthening psychological resilience should be considered a key target in addiction interventions.

Conditions

  • Psychoeducation Study

Interventions

BEHAVIORAL

Structured Psychoeducation Program

A structured psychoeducation program was implemented for individuals with substance use disorder under probation supervision. The program focused on relapse prevention, coping strategies, psychological resilience, and craving management. It was delivered in weekly group sessions over six weeks by a trained mental health professional in a hospital setting. Each session lasted 60 minutes. The intervention was designed to support rehabilitation and treatment processes in outpatient probation services.

Sponsors & Collaborators

  • University of Gaziantep

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-08-20
Primary Completion
2026-02-20
Completion
2026-02-20

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07581353 on ClinicalTrials.gov